Medicare beneficiaries may engage with a multitarget stool DNA test such as Cologuard better than a fecal immunochemical test. Read more.
Thompson Health Gastroenterology relocated to a new outpatient clinic May 4.
The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients. Read more.
CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity.
Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic.
RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.
More articles on surgery centers:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.